CurrentBlue Cross Blue Shield - TexasPolicy CPCPLABO47

Pancreatic Enzyme Testing for Acute Pancreatitis

Defines reimbursement criteria for laboratory measurement of pancreatic enzymes (e.g., serum lipase, amylase, urine amylase, trypsinogen/TAP and related biomarkers) for diagnosis and management of acute pancreatitis for Blue Cross and Blue Shield of Texas members and providers.

Policy Summary

PayerBlue Cross Blue Shield - Texas

PolicyPancreatic Enzyme Testing for Acute Pancreatitis

Policy CodePolicy CPCPLABO47

Change TypeRevisions and additions to reimbursable criteriaremoval of amylase from diagnostic allowance

Effective DateNov 7, 2025

Next Review DateN/A

Key ActionSubmit claims with accurate documentation and appropriate coding; serum lipase reimbursable only for patients presenting with signs/symptoms of acute pancreatitis and subject to listed non-reimbursable scenarios.

SourceLink

POLICY UPDATE CHANGES

Amylase was removed from provisions #1 and #2; measurement of amylase is no longer allowed for the diagnosis of acute pancreatitis.

Revised #2 to specify situations where measurement of serum lipase is not reimbursable (established pancreatitis, more than once per visit, asymptomatic general exam).

Added #3: Measurement of serum amylase is not reimbursable when ordered for anything other than analysis of pancreatic cyst fluid.

Added #7: Measurement of serum lipase is not reimbursable for all other situations or conditions not described.

Note 1 (signs and symptoms of acute pancreatitis) and references revised as part of literature review.

7enumerated reimbursement & non-reimbursable points

6+procedure codes listed

Policy Summary

PayerBlue Cross Blue Shield - Texas

PolicyPancreatic Enzyme Testing for Acute Pancreatitis

Policy CodePolicy CPCPLABO47

Change TypeRevisions and additions to reimbursable criteriaremoval of amylase from diagnostic allowance

Effective DateNov 7, 2025

Next Review DateN/A

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Reimbursement Criteria for Pancreatic Enzyme Testing

Reimbursement criteria for pancreatic enzyme testing

Reimbursement criteria for pancreatic enzyme testing. Covered or not reimbursable scenarios are listed below.

ALL of the following

For individuals presenting with signs and symptoms of acute pancreatitis (see NOTE 1)
Measurement of serum lipase may be reimbursable for initial evaluation of suspected acute pancreatitis.
Measurement of serum lipase is NOT reimbursable in any of the following situations:
- For individuals with an established diagnosis of acute or chronic pancreatitis.
- More than once per visit.
- For asymptomatic individuals during a general exam without abnormal findings.
When ordered for anything other than analysis of pancreatic cyst fluid, measurement of serum amylase is not reimbursable.
For the diagnosis, assessment, prognosis, and/or determination of severity of acute pancreatitis, measurement of serum and urine trypsin/trypsinogen/trypsinogen activation peptide (TAP) is not reimbursable.
For the diagnosis, assessment, prognosis, and/or determination of severity of acute pancreatitis, measurement of the following biomarkers is not reimbursable: C-reactive protein (CRP), Interleukin-6 (IL-6), Interleukin-8 (IL-8), and Procalcitonin.
For individuals presenting with signs and symptoms of acute pancreatitis (see NOTE 1), measurement of urinary amylase concentration for the initial diagnosis of acute pancreatitis is not reimbursable.
For all other situations or conditions not described above, measurement of serum lipase is not reimbursable.

Procedure Codes and Coding Rules

Listed laboratory procedure codes (not exhaustive)CPT

82150	Amylase; serum or plasma
83519	Lipase; independent procedure
83520	Lipase; other (if applicable)
83529	Other pancreatic enzyme tests
83690	Trypsin or related proteolytic enzymes
84145	C-reactive protein (CRP)
86140	Procalcitonin

Repeat testing per visit

ThresholdMeasurement of serum lipase not reimbursable more than once per visit.

ContextApplies when an individual already had a serum lipase measurement during the same outpatient visit or encounter.

Related Non‑reimbursable ScenariosAlso not reimbursable for individuals with established acute or chronic pancreatitis and for asymptomatic individuals during general exams without abnormal findings.

Provider Documentation and Reimbursement Actions

Documentation Required

Submit accurate documentation and code claims per industry standards; claims are subject to edit and policy review

Submit claims with accurate documentation and code services using HIPAA-approved code sets and industry standard coding guidelines; be prepared to provide additional documentation upon request. Claims are subject to code edit protocols and review against plan/contract terms, clinical payment and coding policies, and coding software logic. Serum lipase is only potentially reimbursable for individuals presenting with signs and symptoms of acute pancreatitis; measurements are not reimbursable in specified scenarios (established pancreatitis, asymptomatic general exams, more than once per visit) and serum amylase is not reimbursable except when ordered for analysis of pancreatic cyst fluid.

Code claims per HIPAA-approved code sets and industry standards (CPT, HCPCS, ICD-10-CM/PCS, NDC, DRG, CCI tables).
Provide additional documentation when requested for claim review.
Understand that claims will be evaluated against benefit coverage, provider contract language, medical policies, and code-edit protocols.
Do not expect reimbursement for serum lipase outside defined indications (including more than once per visit) or for serum amylase except for pancreatic cyst fluid analysis.

Clinical Signs, Symptoms, and Test Definitions

Signs and symptoms of acute pancreatitis

Key presenting symptomsMild to severe epigastric pain (may spread to the back), nausea, vomiting.

Associated findingsAbdominal distention, epigastric tenderness, hypoactive bowel sounds, anorexia, diarrhea.

Systemic signsFever, rapid pulse (tachycardia), tachypnea, hypotension, hypoxemia.

Classical signsCullen sign and Grey Turner sign.

Amylase testing

Policy stanceMeasurement of serum amylase is not reimbursable for the diagnosis of acute pancreatitis.